ABBV vs. BDX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and BDX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing BDX’s 49.62 billion USD by roughly 6.47×.
ABBV’s beta of 0.55 points to much larger expected swings compared to BDX’s calmer 0.34, suggesting both higher upside and downside potential.
| Symbol | ABBV | BDX |
|---|---|---|
| Company Name | AbbVie Inc. | Becton, Dickinson and Company |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Instruments & Supplies |
| CEO | Mr. Robert A. Michael CPA | Mr. Thomas E. Polen Jr. |
| Price | 181.8 USD | 173.14 USD |
| Market Cap | 321.13 billion USD | 49.62 billion USD |
| Beta | 0.55 | 0.34 |
| Exchange | NYSE | NYSE |
| IPO Date | January 2, 2013 | February 21, 1973 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABBV and BDX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABBV and BDX, please refer to the table below.
| Symbol | ABBV | BDX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 76.62 | 33.33 |
| Forward PEG Ratio (TTM) | 7.16 | 5.92 |
| Price-to-Sales Ratio (P/S, TTM) | 5.60 | 2.38 |
| Price-to-Book Ratio (P/B, TTM) | 226.35 | 1.98 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | 19.16 |
| EV-to-EBITDA (TTM) | 23.58 | 19.40 |
| EV-to-Sales (TTM) | 6.73 | 3.27 |
| EV-to-Free Cash Flow (TTM) | 25.08 | 26.34 |
Dividend Comparison
ABBV’s dividend yield of 3.51% is about 53% higher than BDX’s 2.30%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | ABBV | BDX |
|---|---|---|
| Dividend Yield (TTM) | 3.51% | 2.30% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and BDX, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ABBV’s current ratio of 0.76 signals a possible liquidity squeeze, while BDX at 1.13 comfortably covers its short-term obligations.
- Both ABBV (quick ratio 0.64) and BDX (quick ratio 0.64) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- ABBV is heavily leveraged (debt-to-equity ratio 49.22), which can boost returns but raises risk if borrowing costs climb, while BDX at 0.76 keeps leverage at a more moderate level.
| Symbol | ABBV | BDX |
|---|---|---|
| Current Ratio (TTM) | 0.76 | 1.13 |
| Quick Ratio (TTM) | 0.64 | 0.64 |
| Debt-to-Equity Ratio (TTM) | 49.22 | 0.76 |
| Debt-to-Assets Ratio (TTM) | 0.51 | 0.35 |
| Interest Coverage Ratio (TTM) | 6.14 | 3.95 |